Filter By Industry
Filter By Tag

Newsroom

GenScript ProBio Press releases

1 - 1 of 1 Press Release

GenScript ProBio as well AbTis enter into an Exclusive Worldwide License Agreement for ADC Targeting
Jun 22, 2022
On the 8th of December 2021, GenScript ProBio entered into a collaboration with AbTis, a Korean biotechnology firm devoted to the research and development of antibody-drug conjugate ("ADC") to give AbTis the exclusive global license for GenScript...


GenScript ProBio RSS Feed